A meeting of experts was convened at the office of the Pharmacy Council of India (PCI), New Delhi, on 19/02/2026 to deliberate upon the draft syllabus of M.Pharm (Medical Devices).

The meeting was graced by the presence of the President, Vice President, Chairman – Education Regulation Committee (ERC), Members of PCI, and invited experts representing academia, regulatory authorities, industry, and the Indian Pharmacopoeia Commission.

The draft syllabus was discussed in detail with special emphasis on regulatory frameworks, quality assurance, design and development of medical devices, clinical evaluation, materiovigilance, and industry alignment. Experts provided critical and constructive suggestions to strengthen academic rigor, enhance industry relevance, and ensure compliance with current regulatory requirements.

Key recommendations included:

• Inclusion of updated national and global regulatory guidelines.
• Strengthening practical and industry-oriented training components.
• Incorporation of emerging technologies and innovation-driven modules.
• Alignment with current standards and pharmacopoeial requirements.
• Enhancement of research and dissertation components with translational focus.

The meeting concluded with consensus to incorporate the suggested modifications and finalize the revised draft syllabus for further approval and notification as per PCI norms.

The deliberations were highly productive and marked an important step toward strengthening specialized pharmaceutical education in the domain of Medical Devices in India.